Enzo Biochem, Inc.
ENZB
$0.5299
-$0.01-1.85%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -147.13% | -165.44% | -193.96% | -228.54% | 198.15% |
| Total Depreciation and Amortization | -8.58% | -23.39% | -38.56% | -52.57% | -46.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.05% | 107.35% | 106.15% | 108.66% | -3,727.60% |
| Change in Net Operating Assets | 104.59% | 59.85% | -154.96% | -144.48% | -203.14% |
| Cash from Operations | 63.70% | 66.30% | 47.49% | 28.98% | -45.46% |
| Capital Expenditure | -3.22% | 48.35% | 68.71% | 80.25% | 61.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -96.06% | -95.79% | -95.71% | -100.55% | 4,041.51% |
| Total Debt Issued | -- | -- | -- | -- | 115.21% |
| Total Debt Repaid | 82.12% | 85.21% | 85.14% | 85.11% | -352.37% |
| Issuance of Common Stock | -- | -- | -- | -- | 2,657.14% |
| Repurchase of Common Stock | 65.61% | 63.60% | 63.60% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.19% | -508.55% | -150.32% | -272.71% | -259.79% |
| Foreign Exchange rate Adjustments | 131.25% | 84.62% | 116.83% | 95.41% | -455.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.23% | -136.81% | -138.29% | -151.02% | 287.82% |